Tasigna
Tasigna is a oncology medication containing Nilotinib, available as 150/200mg tablets.
Details
- Conditions
- Chronic myeloid leukaemia
- Therapeutic Class
- Tyrosine Kinase Inhibitor
- Pharmacological Class
- BCR-ABL Kinase Inhibitor
- Minor Side Effects
- nausea, rash, pruritus, headache
- Moderate Side Effects
- thrombocytopenia, neutropenia, hyperglycaemia
- Dosage Forms
- Capsule, hard
- Administration Route
- Oral use
- Prescription Status
- Prescription medicine
- Originator
- Novartis
- Onset Time
- variable
- Duration
- continuous
- Storage Instructions
- Store below 30°C.
- Drug Interactions
- antacids, clarithromycin
- Age Restrictions
- Not for children.
What you will receive
Tasigna is the originator brand name, made by Novartis. We use it here to identify the medicine only; we are not affiliated with Novartis and do not ship the original Tasigna.
- You receive a generic equivalent: the same active ingredient (Nilotinib) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.